Janux Therapeutics, Inc. - Common Stock - Çeyreklik Bilanço (NASDAQ:JANX) | MetaTrader

Tam grafiği aç Full chart

Haberler

Wall Street Analysts Predict a 155.82% Upside in Janux Therapeutics (JANX): Here's What You Should Know

Here's Why You Should Add JANX Stock to Your Portfolio Now

Janux Therapeutics başkan yardımcısı 28.878 dolarlık hisse sattı

Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates

How Much Upside is Left in Janux Therapeutics (JANX)? Wall Street Analysts Think 180.44%

Undercovered Stocks: Western Digital, SAP, Toast And More

Janux Therapeutics: Strong Buy As Pipeline Advances, Stock Trades Below Cash Value (JANX)

BofA, Janux Therapeutics’in hedef fiyatını düşürdü

Janux kanser tedavisi geliştirme programını sonlandırdı

Bristol-Myers Squibb: 'Strong Buy' As 2026 Milestones Could Bolster Its Prospects (NYSE:BMY)

H.C. Wainwright, Janux Therapeutics için al tavsiyesini yineledi

Will Acute Care Strength Help Universal Health Offset Q1 Rising Costs?